logo

For the Inventor, By the Inventor

Cardiff, United Kingdom

Verona Pharma Plc


USPTO Granted Patents = 19

% Expired Patents = 5.3



Trademarks = 6

Forward Citations = 117

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Peter Lionel Spargo (9 out of 9 patents)

silverMedal Edward James French (6 out of 6 patents)

bronzeMedal Phillip A Haywood (4 out of 4 patents)

4.  Michael J A Walker (4 out of 16 patents)

5.  Julian Scott Northen (3 out of 37 patents)

6.  Mario Cazzola (3 out of 3 patents)

7.  Luigino Calzetta (3 out of 4 patents)

8.  Katharine Abbott-Banner (2 out of 2 patents)

9.  John Hanrahan (2 out of 2 patents)

10.  David Thomas (2 out of 2 patents)

11.  David Jack (2 out of 4 patents)

12.  Alexander W Oxford (2 out of 58 patents)

13.  John Mykytiuk (2 out of 6 patents)

14.  Kathleen Rickard (2 out of 2 patents)

15.  Thomas Bengtsson (2 out of 2 patents)


19 patents:

1. 12758511 - Ensifentrine (RPL554) for increasing trough lung function in COPD (2026-10-13),
2. 12734139 - Ensifentrine for decreasing the frequency/severity of COPD exacerbations (2026-09-15),
3. 12409180 - Formulation production process (2025-09-09),
4. 12251384 - Particulate composition (2025-03-18),
5. 12194045 - Particulate composition (2025-01-14),
6. 12168011 - Formulation production process (2024-12-17),
7. 11759467 - Treatment (2023-09-19),
8. 11491155 - Salt of a pyrimido[6,1-A]isoquinolin-4-one compound (2022-11-08),
9. 10945950 - Liquid inhalation formulation comprising RPL554 (2021-03-16),
10. 10864213 - Treatment (2020-12-15),
11. 10710998 - Compound and process (2020-07-14),
12. 10471063 - Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist (2019-11-12),
13. 10463665 - Salt of a pyrimido[6,1-A]isoquinolin-4-one compound (2019-11-05),
14. 9956171 - Liquid inhalation formulation comprising RPL554 (2018-05-01),
15. 9717732 - Drug combination (2017-08-01),
Company Overview
Verona Pharma Plc is a clinical-stage biopharmaceutical company based in Cardiff, UK, focused on developing innovative therapies for respiratory diseases. The company specializes in the research and development of novel treatments aimed at addressing unmet medical needs in conditions such as chronic obstructive pulmonary disease (COPD) and asthma. Verona Pharma leverages advanced drug development techniques to create effective solutions that enhance patient care and improve quality of life in the respiratory health domain.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#5 in Cardiff

#928 in United Kingdom

#32,693 in the World

Cardiff, GB
Cardiff, United Kingdom

Verona Pharma Plc

Forward Citations = 117

19 inventors:

goldMedal Peter Lionel Spargo (9 out of 9 patents)

silverMedal Edward James French (6 out of 6 patents)

bronzeMedal Phillip A Haywood (4 out of 4 patents)

4.  Michael J A Walker (4 out of 16 patents)

5.  Julian Scott Northen (3 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Verona Pharma Plc. Retrieved from https://idiyas.com/company/verona-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…